万达电影(002739) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was ¥3,461,020,211.59, a decrease of 16.01% compared to ¥4,120,927,519.82 in the same period last year[3] - Net profit attributable to shareholders was ¥44,988,747.91, down 91.42% from ¥524,218,666.57 year-on-year[3] - Basic and diluted earnings per share were both ¥0.0202, representing a decrease of 91.40% from ¥0.2350 in the same period last year[3] - Total operating revenue for Q1 2022 was CNY 3,461,020,211.59, a decrease of 16% compared to CNY 4,120,927,519.82 in the same period last year[15] - Net profit for Q1 2022 was CNY 46,685,613.81, significantly lower than CNY 533,821,990.44 in Q1 2021, indicating a challenging market environment[16] - The company reported a net profit attributable to shareholders of CNY 112.76 million, a significant decline from CNY 522.15 million in Q1 2021[19] - The total comprehensive income for the period was CNY 114.20 million, a decrease from CNY 531.75 million in Q1 2021[19] Cash Flow and Liquidity - The net cash flow from operating activities was ¥356,147,874.18, a decline of 79.04% compared to ¥1,699,430,576.37 in the previous year[3] - Cash and cash equivalents at the end of Q1 2022 totaled CNY 4.40 billion, compared to CNY 5.12 billion at the end of Q1 2021, reflecting a decrease of 13.9%[19] - The cash and cash equivalents decreased to CNY 1,000,000,000.00 from CNY 1,500,000,000.00, reflecting a liquidity challenge[16] - Cash outflow from investing activities was CNY 309.11 million, compared to CNY 459.38 million in the previous year, indicating a decrease of 32.7%[19] - Cash inflow from financing activities was CNY 2.96 billion, an increase of 41.6% from CNY 2.09 billion in Q1 2021[19] - The company experienced a net increase in cash and cash equivalents of CNY 435.05 million during the quarter, compared to an increase of CNY 161.09 million in the same period last year[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥29,890,571,329.06, an increase of 2.51% from ¥29,159,583,437.21 at the end of the previous year[3] - Total liabilities rose to CNY 20,700,647,488.51, compared to CNY 20,083,861,376.39, indicating an increase of about 3.1%[15] - The total equity attributable to shareholders increased to CNY 9,040,819,204.72 from CNY 8,928,054,399.43, showing a growth of approximately 1.25%[15] Operational Highlights - The company reported a significant decrease in net profit primarily due to the absence of major films released during the Spring Festival and the impact of the pandemic on cinema operations[6] - The company experienced a 47.64% increase in advance payments for film investments, totaling ¥251,652,626.22[6] - The company reported a 134.23% increase in cash flow from financing activities, amounting to ¥369,429,503.96 due to net inflow from borrowings[6] - In Q1 2022, the total box office revenue was 1.398 billion RMB, a year-on-year decrease of 22.79%[10] - The company achieved a box office of 1.94 billion RMB (excluding service fees), down 14.3% year-on-year, with 44.2 million admissions, a decrease of 20%[10] - The company's market share in the domestic cinema sector reached 16%, an increase of 1.5 percentage points compared to the same period last year[10] - As of March 31, 2022, the company operated 800 cinemas and 6,816 screens domestically, including 707 directly operated cinemas with 6,135 screens[10] - The Australian cinema chain reported a box office of 249 million RMB, a year-on-year increase of 54.7%[10] - The film "Miracle: Stupid Kid," invested by the company, achieved a box office of 1.376 billion RMB during the Spring Festival[10] - The company has over 400 cinemas temporarily closed due to the pandemic, significantly impacting its operations[10] - The company is actively seeking rent reductions and financial support during the pandemic[12] Cost Management - Total operating costs amounted to CNY 3,438,834,878.36, down from CNY 3,608,766,033.74, reflecting a cost reduction strategy[16] - The company reported a decrease in sales expenses to CNY 255,391,637.38 from CNY 388,183,926.75, reflecting cost control measures[16] - Research and development expenses slightly increased to CNY 7,049,324.37 from CNY 6,951,290.41, indicating continued investment in innovation[16] Other Information - The weighted average return on equity was 0.50%, down 5.06% from 5.56% in the previous year[3] - The company did not conduct an audit for the Q1 2022 report[20]